Jacob Asset Management Of New York LLC Arcturus Therapeutics Holdings Inc. Transaction History
Jacob Asset Management Of New York LLC
- $70.6 Million
- Q3 2023
A detailed history of Jacob Asset Management Of New York LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Jacob Asset Management Of New York LLC holds 7,677 shares of ARCT stock, worth $92,124. This represents 0.28% of its overall portfolio holdings.
Number of Shares
7,677
Previous 10,077
23.82%
Holding current value
$92,124
Previous $289,000
32.18%
% of portfolio
0.28%
Previous 0.33%
Shares
12 transactions
Others Institutions Holding ARCT
# of Institutions
167Shares Held
25.9MCall Options Held
163KPut Options Held
173K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$56.3 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$31.8 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$24.8 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$24.8 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$23.2 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $319M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...